( SEVAMED 2001)

(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines & Drugs)

(Click Here for Abstract)

Back To Content Page

1622.  Bhamarapravati N.  Sutee Y.Live attenuated tetravalent dengue vaccine. Vaccine. 18 Suppl 2:44-7, 2000 May 26.

1623. Chaturvedi UC.  Agarwal  R.  Elbishbishi  EA.  Mustafa  AS.  Cytokine cascade in dengue hemorrhagic fever: implications for  pathogenesis. [Review] [45 refs] FEMS Immunology & Medical Microbiology.  28(3):183-8, 2000 Jul.

1624. Jacobs MG.  Robinson PJ.  Bletchly C.  Mackenzie JM.  Young PR. Dengue virus nonstructural protein 1 is expressed in a  glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. FASEB Journal. 14(11):1603-10, 2000 Aug.

1625. King CA.  Marshall JS.  Alshurafa H.  Anderson R. Release of vasoactive cytokines by antibody-enhanced dengue virus  infection of a human mast cell / basophil line. Journal of Virology.  74(15):7146-50, 2000 Aug.

1626. Lucas GN.  Amerasinghe A.  Sriranganathan S. Dengue haemorrhagic fever in Sri Lanka.  Indian Journal of Pediatrics.  67(7):503-4, 2000 Jul.

1627. McBride  WJ.  Bielefeldt-Ohmann  H.  Dengue  viral infections; pathogenesis and epidemiology. [Review] [97 refs] Microbes & Infection.  2(9):1041-50, 2000 Jul.

1628. Wali JP.  Biswas A.  Aggarwal P.  Wig N.  Handa R. Validity of tourniquet test in dengue  haemorrhagic  fever.  Journal  of  the  Association  of  Physicians  of  India. 47(2):203-4, 1999 Feb.

1629.Wu SJ. Grouard-Vogel G.  Sun W.  Mascola JR.  Brachtel E.  Putvatana R. Louder MK. Filgueira L. Marovich MA. Wong HK. Blauvelt A. Murphy GS. Robb ML. Innes BL.  Birx  DL.  Hayes  CG.  Frankel  SS.  Human  skin  Langerhans  cells  are targets of             dengue virus infection [see comments].  Nature Medicine.  6(7):816-20, 2000 Jul.

1630. Yoshida  M.  Igarashi  A.  Suwendra  P.   Inada  K.  Maha  MS.   Kari  K. Suda  H. Antonio MT.  Arhana BNP.  Takikawa Y.  Maesawa S.  Yoshida H.  Chiba M. The first  report  on  human  cases  serologically diagnosed as Japanese  encephalitis in Indonesia. Southeast Asian Journal of Tropical Medicine & Public Health. 30(4): 698-706, 1999 Dec.

2116.      Anonymous. From the Centers for Disease Control and Prevention. Underdiagnosis of dengue--Laredo, Texas, 1999. JAMA. 285(7):877,2001 Feb 21.

2117.      Beasley DW.  Aaskov JG. Epitopes on the dengue 1 virus envelope protein  recognized by neutralizing igm monoclonal antibodies. Virology.  279(2):447-58, 2001 Jan 20.

2118.      Bethell DB.  Gamble J.  Pham PL.  Nguyen MD.  Tran TH.  Ha TH.  Tran TN.  Dong TH.  Gartside IB.  White NJ.  Day NP. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clinical Infectious Diseases. 32(2):243-53, 2001 Jan 15.

2119.      Carbajo AE.  Schweigmann N.  Curto SI.  de Garin A.  Bejaran R.  Dengue transmission risk maps of Argentina. Tropical Medicine & International Health.  6(3):170-83, 2001 Mar.

2120.                                    Fouque F.  Vazeille M.  Mousson L.  Gaborit P.  Carinci R.  Issaly J.  Rodhain F.  Failloux AB. Aedes aegypti in French Guiana: susceptibility to a dengue virus.  Tropical Medicine & International Health.  6(1):76-82, 2001 Jan.

2121.      Ho LJ.  Wang JJ.  Shaio MF.  Kao CL.  Chang DM.  Han SW.  Lai JH.  Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production  Journal of Immunology.  166(3):1499-506, 2001 Feb 1.

2122.      Lin CF.  Lei HY.  Liu CC.  Liu HS.  Yeh TM.  Wang ST.  Yang TI.  Sheu FC.  Kuo CF.  Lin YS. Generation of IgM anti-platelet autoantibody in dengue patients. Journal of Medical Virology.  63(2):143-9, 2001 Feb.

2123.      Nawa M.  Takasaki T.  Yamada KI.  Akatsuka T.  Kurane I. Development of dengue IgM-capture enzyme-linked immunosorbent assay with higher sensitivity using monoclonal detection antibody.  Journal of Virological Methods.  92(1):65-70, 2001 Mar.

2124.      Ooi EE.  Hart TJ.  Tan HC.  Chan SH. Dengue seroepidemiology in Singapore.  Lancet.  357(9257):685-6, 2001 Mar 3.

2125.      Shurtleff AC.  Beasley DW.  Chen JJ.  Ni H.  Suderman MT.  Wang H.  Xu R.  Wang E.  Weaver SC.  Watts DM.  Russell KL.  Barrett AD. Genetic variation in the 3' non-coding region of dengue viruses. Virology.  281(1):75-87, 2001 Mar 1.

2126.      Sriburi R.  Keelapang P.  Duangchinda T.  Pruksakorn S.  Maneekarn N.  Malasit P.  Sittisombut N. Construction of infectious dengue 2 virus cDNA clones using high copy number plasmid. Journal of Virological Methods.  92(1):71-82, 2001 Mar.

2127.      Sudiro TM.  Zivny J.  Ishiko H.  Green S.  Vaughn DW.  Kalayanarooj S.  Nisalak A.  Norman JE.  Ennis FA.  Rothman AL. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor reverse transcription-polymerase chain reaction. Journal of Medical Virology.  63(1):29-34, 2001 Jan.

2128.      Yang KD.  Yeh WT.  Yang MY.  Chen RF.  Shaio MF. Antibody-dependent enhancement of heterotypic dengue infections involved in suppression of IFNgamma production.  Journal of Medical Virology.  63(2):150-7, 2001 Feb.

2594.      Alvarez M.  Guzman MG.  Pupo M.  Morier L.  Bravo J.  Rodriguez R. Study of biologic attributes of Cuban dengue 2 virus after serial passage in primary dog kidney cells. International Journal of Infectious Diseases.  5(1):35-9, 2001.

2595.      Libraty DH.  Pichyangkul S.  Ajariyakhajorn C.  Endy TP.  Ennis FA.  Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis.  Journal of Virology.  75(8):3501-8, 2001 Apr.


(Click Here for Abstract)

Back To Content Page